Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study.

[1]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[2]  M. Margaglione,et al.  Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  P. Elwood,et al.  Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study , 2002, Diabetologia.

[4]  M. Laakso,et al.  Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. , 2001, Diabetes care.

[5]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[6]  F. Hu.  Re: "Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome". , 2001, American journal of epidemiology.

[7]  J. Meigs,et al.  Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. , 2000, American journal of epidemiology.

[8]  P. Wahl,et al.  Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. , 2000, American journal of epidemiology.

[9]  H. Pijl,et al.  Consumption of black and green tea has no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals , 2000, European Journal of Clinical Nutrition.

[10]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[11]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[12]  M. Laakso,et al.  Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[13]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[14]  C. Bogardus,et al.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. , 2000, American journal of epidemiology.

[15]  G. Hallmans,et al.  High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. , 1999, Metabolism: clinical and experimental.

[16]  M. Laakso,et al.  Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. , 1999, Circulation.

[17]  J. Levy,et al.  Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes , 1999, Diabetologia.

[18]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[19]  L. Bouter,et al.  Insulin and risk of cardiovascular disease: a meta-analysis. , 1998, Circulation.

[20]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[21]  Ralph B D'Agostino,et al.  Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study , 1997, Diabetes.

[22]  C. Peschle,et al.  Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. , 1997, The American journal of cardiology.

[23]  S. Coppack,et al.  Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome , 1997, Diabetes.

[24]  J. Yudkin,et al.  The Relationship of Concentrations of Insulin and Proinsulin-Like Molecules With Coronary Heart Disease Prevalence and Incidence: A study of two ethnic groups , 1997, Diabetes Care.

[25]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[26]  J. Yudkin,et al.  Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects — evidence against a modulating role for insulin , 1995, Diabetologia.

[27]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[28]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[29]  Larry Hatcher,et al.  A Step-by-Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modeling , 1994 .

[30]  T. Sakamoto,et al.  Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. , 1993, American heart journal.

[31]  S. Thompson,et al.  Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  T. Meade,et al.  Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.

[33]  M. Laakso,et al.  How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.

[34]  M. Alessi,et al.  Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis , 1991, Diabetologia.

[35]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[36]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.